Overview

NPC-06 to Acute Pain in Herpes Zoster

Status:
Terminated
Trial end date:
2021-02-28
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate the efficiency of pain relief and the safety of NPC-06 for the acute pain in herpes zoster in the placebo-controlled double-blind parallel group trial, in addition to explore the effective concentration of NPC-06.
Phase:
Phase 2
Details
Lead Sponsor:
Nobelpharma